Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur les pandémies grippales - Exploration (Accueil)

Index « Keywords » - entrée « Enzyme Inhibitors (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Enzyme Inhibitors (pharmacology) < Enzyme Inhibitors (therapeutic use) < Enzyme immunoassay  Facettes :

List of bibliographic references indexed by Enzyme Inhibitors (therapeutic use)

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000503 (2018) César Parra-Rojas ; Van Kinh Nguyen ; Gustavo Hernandez-Mejia ; Esteban A. Hernandez-VargasNeuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
000844 (2016) Robert Moss [Australie] ; James M. Mccaw [Australie] ; Allen C. Cheng [Australie] ; Aeron C. Hurt [Australie] ; Jodie Mcvernon [Australie]Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
000B96 (2015) Norio Sugaya [Japon] ; Yuko Sakai-Tagawa ; Masahiro Bamba ; Rieko Yasuhara ; Masahiko Yamazaki ; Chiharu Kawakami ; Yoshio Yamaguchi ; Yoshiaki Ide ; Masataka Ichikawa ; Keiko Mitamura ; Yoshihiro Kawaoka [États-Unis]Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
001231 (2013) Barbara Rath [Oman] ; Franziska Tief ; Katharina Karsch ; Susann Muehlhans ; Patrick Obermeier ; Eleni Adamou ; Xi Chen ; Lea Seeber ; Christian Peiser ; Christian Hoppe ; Max Von Kleist ; Tim Conrad ; Brunhilde SchweigerTowards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.
001293 (2013) J Kevin Yin [Australie] ; Leon Heron ; Glenn Salkeld ; Harunor Rashid ; Robert BooyOseltamivir use in adolescents and adults: clinical and economic considerations.
003053 (2010) Jun Hayashi ; Masayuki Murata ; Norihiro Furusyo ; Takayuki Hoshina ; Nobuyuki Shimono[Measures taken by a university hospital for the prevention and control of the 2009 H1N1 influenza].
003F80 (2009) Poramate Pitak-Arnnop [Allemagne, France] ; Stefan Schubert [Allemagne] ; Kittipong Dhanuthai [Thaïlande] ; Kraison Sappayatosok [Thaïlande] ; Ute Bauer [Allemagne] ; Pichit Ngamwannagul [Thaïlande] ; Uwe Gerd Liebert [Allemagne] ; Alexander Hemprich [Allemagne]Swine-origin H1N1 influenza A virus and dental practice: a critical review
004606 (2008) Varsha Gupta ; Nidhi SinglaAvian influenza: current scenario.
004904 (2008) Nicole M. Bouvier [États-Unis] ; Anice C. Lowen [États-Unis] ; Peter Palese [États-Unis]Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol
004E51 (2007) Martin Crusat [Viêt Nam] ; Menno D. De Jong [Viêt Nam]Neuraminidase inhibitors and their role in avian and pandemic influenza
004F41 (2006) Ingo Stock [Allemagne][Human influenza].
005060 (2006) Anthony S. Fauci [États-Unis]Seasonal and Pandemic Influenza Preparedness: Science and Countermeasures
005078 (2006) Justin R. Ortiz [Géorgie (pays), États-Unis] ; David K. Shay [Géorgie (pays)] ; Laura A. Liedtke [États-Unis] ; Joseph S. Bresee [Géorgie (pays)] ; Larry J. Strausbaugh [États-Unis]A National Survey of the Infectious Diseases Society of America Emerging Infections Network concerning Neuraminidase Inhibitor Prescription Practices and Pandemic Influenza Preparations
005089 (2006) Jane Democratis [Royaume-Uni] ; Manish Pareek [Royaume-Uni] ; Iain Stephenson [Royaume-Uni]Use of neuraminidase inhibitors to combat pandemic influenza
005448 (2005) L. Bonneux [Belgique][The threatening influenza pandemic: a national store ofoseltamivir is a waste of money].
005456 (2005) Jordi Reina [Espagne][Neuraminidase inhibitors and their potential use in the avian influenza pandemic].
005490 (2005) John Oxford [Royaume-Uni]Oseltamivir in the management of influenza.
005828 (2004) John Oxford [Royaume-Uni] ; Shobana Balasingam [Royaume-Uni] ; Rob Lambkin [Royaume-Uni]A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community
005872 (2003) Marianne L. L. Van Genugten [Pays-Bas] ; Marie-Louise A. Heijnen [Pays-Bas] ; Johannes C. Jager [Pays-Bas]Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis
005879 (2003) J S Oxford [Royaume-Uni] ; A. Mann ; R. LambkinA designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Enzyme Inhibitors (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Enzyme Inhibitors (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Enzyme Inhibitors (therapeutic use)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021